Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects

NEW YORK (April 29, 2009) -- In searching for a simple way to identify individuals with smoking-related lung injury, scientists at Weill Cornell Medical College have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 inhibitors increases the risk of heart problems among users.

Read the whole article on Science Blog

More from Science Blog